Literature DB >> 20072870

Current trends in liposome research.

Tamer A Elbayoumi1, Vladimir P Torchilin.   

Abstract

Among the several drug delivery systems, liposomes--phospholipid nanosized vesicles with a bilayered membrane structure--have drawn a lot of interest as advanced and versatile pharmaceutical carriers for both low and high molecular weight pharmaceuticals. At present, liposomal formulations span multiple areas, from clinical application of the liposomal drugs to the development of various multifunctional liposomal systems to be used in therapy and diagnostics. This chapter provides a brief overview of various liposomal products currently under development at experimental and preclinical level.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20072870     DOI: 10.1007/978-1-60327-360-2_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  28 in total

1.  Post-lumpectomy intracavitary retention and lymph node targeting of (⁹⁹m)Tc-encapsulated liposomes in nude rats with breast cancer xenograft.

Authors:  Shihong Li; Beth Goins; William T Phillips; Marcela Saenz; Pamela M Otto; Ande Bao
Journal:  Breast Cancer Res Treat       Date:  2010-12-23       Impact factor: 4.872

2.  Feasibility of eradication of breast cancer cells remaining in postlumpectomy cavity and draining lymph nodes following intracavitary injection of radioactive immunoliposomes.

Authors:  Shihong Li; Beth Goins; Brian A Hrycushko; William T Phillips; Ande Bao
Journal:  Mol Pharm       Date:  2012-08-23       Impact factor: 4.939

Review 3.  Current trends in the use of liposomes for tumor targeting.

Authors:  Pranali P Deshpande; Swati Biswas; Vladimir P Torchilin
Journal:  Nanomedicine (Lond)       Date:  2013-09       Impact factor: 5.307

4.  Inflammatory monocyte/macrophage modulation by liposome-entrapped spironolactone ameliorates acute lung injury in mice.

Authors:  Wen-Jie Ji; Yong-Qiang Ma; Xin Zhang; Li Zhang; Yi-Dan Zhang; Cheng-Cheng Su; Guo-An Xiang; Mei-Ping Zhang; Zhi-Chun Lin; Lu-Qing Wei; Peizhong P Wang; Zhuoli Zhang; Yu-Ming Li; Xin Zhou
Journal:  Nanomedicine (Lond)       Date:  2016-05-12       Impact factor: 5.307

5.  Novel multifunctional theranostic liposome drug delivery system: construction, characterization, and multimodality MR, near-infrared fluorescent, and nuclear imaging.

Authors:  Shihong Li; Beth Goins; Lujun Zhang; Ande Bao
Journal:  Bioconjug Chem       Date:  2012-05-22       Impact factor: 4.774

6.  On the electroporation thresholds of lipid bilayers: molecular dynamics simulation investigations.

Authors:  Andraž Polak; Daniel Bonhenry; François Dehez; Peter Kramar; Damijan Miklavčič; Mounir Tarek
Journal:  J Membr Biol       Date:  2013-06-19       Impact factor: 1.843

Review 7.  Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles.

Authors:  Zhigang Ju; Wei Sun
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 8.  Potential of helper-dependent Adenoviral vectors in CRISPR-cas9-mediated lung gene therapy.

Authors:  Ranmal Avinash Bandara; Ziyan Rachel Chen; Jim Hu
Journal:  Cell Biosci       Date:  2021-07-23       Impact factor: 7.133

9.  Nano - drug Delivery of Apoptosis Activator 2 to AGS Cells by Liposomes Conjugated with Anti-TROP2 Antibody.

Authors:  Taghi Naserpour Farivar; Reza Najafipour; Pouran Johari
Journal:  N Am J Med Sci       Date:  2012-11

10.  Creation of lung-targeted dexamethasone immunoliposome and its therapeutic effect on bleomycin-induced lung injury in rats.

Authors:  Xue-Yuan Chen; Shan-Mei Wang; Nan Li; Yang Hu; Yuan Zhang; Jin-Fu Xu; Xia Li; Jie Ren; Bo Su; Wei-Zhong Yuan; Xin-Rong Teng; Rong-Xuan Zhang; Dian-Hua Jiang; Xavier Mulet; Hui-Ping Li
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.